Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A0A3Q8I9Z0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 6 |
GO:0005488 | binding | 1 | 8 |
GO:0008270 | zinc ion binding | 6 | 6 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0046914 | transition metal ion binding | 5 | 6 |
GO:0097159 | organic cyclic compound binding | 2 | 6 |
GO:1901363 | heterocyclic compound binding | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.643 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.463 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.655 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.469 |
CLV_PCSK_PC1ET2_1 | 44 | 46 | PF00082 | 0.655 |
DOC_MAPK_gen_1 | 73 | 81 | PF00069 | 0.465 |
DOC_MAPK_RevD_3 | 61 | 75 | PF00069 | 0.553 |
DOC_PP4_FxxP_1 | 19 | 22 | PF00568 | 0.615 |
DOC_USP7_MATH_1 | 5 | 9 | PF00917 | 0.708 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.634 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.653 |
LIG_14-3-3_CanoR_1 | 16 | 20 | PF00244 | 0.549 |
LIG_Actin_WH2_2 | 75 | 90 | PF00022 | 0.569 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.724 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.499 |
LIG_LIR_Apic_2 | 18 | 22 | PF02991 | 0.424 |
LIG_LIR_Gen_1 | 66 | 77 | PF02991 | 0.618 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.550 |
LIG_PDZ_Class_1 | 91 | 96 | PF00595 | 0.534 |
LIG_PTB_Apo_2 | 22 | 29 | PF02174 | 0.454 |
LIG_SH2_CRK | 20 | 24 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 20 | 23 | PF00017 | 0.517 |
LIG_TRAF2_1 | 90 | 93 | PF00917 | 0.618 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.556 |
MOD_CK2_1 | 87 | 93 | PF00069 | 0.525 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.739 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.529 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.718 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.700 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.588 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.723 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.586 |
MOD_PKA_1 | 44 | 50 | PF00069 | 0.528 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.543 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.542 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.579 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.629 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.647 |
MOD_SUMO_rev_2 | 85 | 90 | PF00179 | 0.692 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.556 |
TRG_ER_diArg_1 | 72 | 74 | PF00400 | 0.503 |
TRG_NLS_MonoExtC_3 | 43 | 49 | PF00514 | 0.658 |
TRG_NLS_MonoExtN_4 | 41 | 48 | PF00514 | 0.666 |